Skip to main content

Pfizer income statement

  • PFE · NYSE
  • Pharmaceuticals
  • S&P 500
$28.89+0.21%Close 13 Nov 2026

Pfizer reported revenue of $62.6 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), down 1.6% from fiscal 2024. Net income was $7.77 billion and diluted earnings per share $1.36.

From Pfizer's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Pfizer income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$48.42B$48.30B$49.27B$65.17B$61.03B$54.66B$51.58B$49.60B$48.85B$52.82B$52.55B$40.83B$40.91B$41.65B$81.29B$101.2B$59.55B$63.63B$62.58B$63.63B
Revenue growth—−0.3%+2.0%+32.3%−6.3%−10.4%−5.6%−3.8%−1.5%+8.1%−0.5%−22.3%+0.2%+1.8%+95.2%+24.5%−41.1%+6.8%−1.6%—
Net interest income————−$1.23B−$1.14B−$1.01B−$935.0M−$728.0M−$716.0M−$879.0M−$983.0M−$1.35B−$1.38B−$1.25B−$987.0M−$585.0M−$2.55B−$2.07B−$2.21B
Cost of revenue$11.24B$8.11B$8.46B$14.79B$12.50B$9.82B$9.59B$9.58B$9.65B$12.33B$11.23B$8.99B$8.05B$8.48B$30.82B$34.34B$24.95B$17.85B$16.07B$16.94B
Gross profit$37.18B$40.18B$40.81B$50.38B$48.53B$44.84B$42.00B$40.03B$39.20B$40.49B$41.32B$31.84B$32.85B$33.17B$50.47B$66.83B$34.60B$45.78B$46.51B$46.69B
Gross margin76.8%83.2%82.8%77.3%79.5%82.0%81.4%80.7%80.3%76.7%78.6%78.0%80.3%79.6%62.1%66.1%58.1%71.9%74.3%73.4%
Selling, general and administrative$15.63B$14.54B$14.75B$18.97B$17.58B$15.17B$14.36B$14.10B$14.81B$14.84B$14.80B$12.61B$12.73B$11.60B$12.70B$13.68B$14.77B$14.73B$13.79B$13.81B
Operating income—$10.21B$11.91B$11.27B$13.16B$12.76B$17.13B$13.60B$10.16B$12.14B$13.72B$14.00B$12.89B$8.48B$19.43B$35.79B$1.28B$12.41B$14.24B$13.64B
Operating margin—21.1%24.2%17.3%21.6%23.4%33.2%27.4%20.8%23.0%26.1%34.3%31.5%20.4%23.9%35.4%2.1%19.5%22.8%21.4%
Interest expense—$516.0M$1.23B$1.80B$1.68B$1.52B$1.41B$1.36B$1.20B$1.19B$1.27B$1.32B$1.57B$1.45B$1.29B$1.24B$2.21B$3.09B$2.67B$2.71B
Income before tax$9.28B$9.69B$10.67B$9.47B$11.48B$11.24B$15.72B$12.24B$8.96B$8.35B$12.30B$3.59B$11.32B$7.04B$24.31B$34.73B$1.06B$8.02B$7.52B$4.26B
Income tax expense$1.02B$1.65B$2.15B$1.15B$3.62B$2.22B$4.31B$3.12B$1.99B$1.12B−$9.05B−$266.0M$583.0M$370.0M$1.85B$3.33B−$1.11B−$28.00M−$266.0M$186.0M
Effective tax rate11.0%17.0%20.1%12.2%31.5%19.8%27.4%25.5%22.2%13.4%−73.5%−7.4%5.1%5.3%7.6%9.6%−105%−0.3%−3.5%4.4%
Net income$8.14B$8.10B$8.63B$8.26B$10.01B$14.57B$22.00B$9.13B$6.96B$7.21B$21.31B$11.15B$16.03B$9.16B$21.98B$31.37B$2.12B$8.03B$7.77B$4.03B
Net margin16.8%16.8%17.5%12.7%16.4%26.7%42.7%18.4%14.2%13.7%40.6%27.3%39.2%22.0%27.0%31.0%3.6%12.6%12.4%6.3%
Net income to common shareholders—$8.10B$8.63B$8.26B$10.01B$14.57B$22.00B$9.13B$6.96B$7.21B$21.31B$11.15B$16.03B$9.16B$21.98B$31.37B$2.12B$8.03B$7.77B$4.03B
EPS · diluted$1.17$1.20$1.23$1.02$1.27$1.94$3.19$1.42$1.11$1.17$3.52$1.87$2.82$1.63$3.85$5.47$0.37$1.41$1.36$0.70
Diluted weighted average shares6.9B6.8B7.0B8.1B7.9B7.5B6.9B6.4B6.3B6.2B6.1B6.0B5.7B5.6B5.7B5.7B5.7B5.7B5.7B5.7B
Basic weighted average shares6.9B6.7B7.0B8.0B7.8B7.4B6.8B6.3B6.2B6.1B6.0B5.9B5.6B5.6B5.6B5.6B5.6B5.7B5.7B5.7B
EBITDA—$15.30B$16.66B$19.67B$21.86B$20.16B$23.44B$19.14B$15.32B$17.90B$19.99B$20.15B$18.65B$13.17B$24.62B$40.85B$7.57B$19.42B$20.84B$20.14B
EBITDA margin—31.7%33.8%30.2%35.8%36.9%45.4%38.6%31.4%33.9%38.0%49.4%45.6%31.6%30.3%40.4%12.7%30.5%33.3%31.7%
Depreciation & amortization$5.20B$5.09B$4.76B$8.40B$8.70B$7.39B$6.31B$5.54B$5.16B$5.76B$6.27B$6.15B$5.75B$4.68B$5.19B$5.06B$6.29B$7.01B$6.59B$6.50B
Stock-based compensation$437.0M$384.0M$349.0M$405.0M$419.0M$481.0M$523.0M$586.0M$669.0M$691.0M$840.0M$923.0M$687.0M$755.0M$1.18B$872.0M$525.0M$877.0M$799.0M$1.11B
Dividends per share———$0.72$0.80$0.88$0.96$1.04$1.12$1.22$1.30$1.38$1.46$1.53$1.57$1.61$1.65$1.69$1.72$1.72

Quarterly

Pfizer income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$13.51B$14.88B$13.28B$17.70B$17.76B$13.71B$14.65B$16.65B$17.56B$14.45B$15.03B$16.58B
Net interest income−$80.00M−$661.0M−$648.0M−$668.0M−$569.0M−$511.0M−$498.0M−$514.0M−$545.0M−$554.0M−$554.0M−$554.0M
Cost of revenue$7.56B$3.38B$3.30B$5.26B$5.91B$2.85B$3.78B$4.17B$5.27B$3.55B$4.09B$4.03B
Gross profit$5.95B$11.50B$9.98B$12.44B$11.85B$10.87B$10.88B$12.48B$12.29B$10.90B$10.94B$12.55B
Gross margin44.0%77.3%75.2%70.3%66.7%79.3%74.2%74.9%70.0%75.4%72.8%75.7%
Selling, general and administrative$4.58B$3.50B$3.72B$3.24B$4.27B$3.03B$3.42B$3.19B$4.16B$2.96B$3.41B$3.28B
Operating income−$4.29B$4.10B$1.00B$4.96B$2.35B$3.74B$3.78B$3.85B$2.87B$4.03B$3.06B$3.67B
Operating margin−31.7%27.6%7.6%28.0%13.2%27.3%25.8%23.1%16.4%27.9%20.4%22.1%
Interest expense$688.0M$790.0M$778.0M$783.0M$739.0M$654.0M$654.0M$652.0M$711.0M$668.0M$667.0M$662.0M
Income before tax−$4.13B$3.42B−$103.0M$4.71B−$10.00M$2.79B$3.04B$3.33B−$1.64B$3.17B−$653.0M$3.38B
Income tax expense−$795.0M$293.0M−$134.0M$234.0M−$421.0M−$189.0M$141.0M−$216.0M−$2.00M$461.0M−$407.0M$134.0M
Effective tax rate19.3%8.6%130%5.0%4210%−6.8%4.6%−6.5%0.1%14.5%62.3%4.0%
Net income−$3.37B$3.12B$41.00M$4.46B$410.0M$2.97B$2.91B$3.54B−$1.65B$2.69B−$248.0M$3.24B
Net margin−24.9%20.9%0.3%25.2%2.3%21.6%19.9%21.3%−9.4%18.6%−1.6%19.6%
Net income to common shareholders−$3.37B$3.12B$41.00M$4.46B$410.0M$2.97B$2.91B$3.54B−$1.65B$2.69B−$248.0M$3.24B
EPS · diluted−$0.59$0.55$0.01$0.78$0.07$0.52$0.51$0.62−$0.29$0.47−$0.04$0.56
Diluted weighted average shares5.7B5.7B5.7B5.7B5.7B5.7B5.7B5.7B5.7B5.7B5.7B5.8B
Basic weighted average shares5.6B5.7B5.7B5.7B5.7B5.7B5.7B5.7B5.7B5.7B5.7B5.7B
EBITDA−$2.62B$5.84B$2.73B$6.71B$4.14B$5.36B$5.41B$5.51B$4.56B$5.64B$4.68B$5.25B
EBITDA margin−19.4%39.2%20.6%37.9%23.3%39.1%36.9%33.1%26.0%39.1%31.2%31.7%
Depreciation & amortization$1.67B$1.74B$1.73B$1.75B$1.79B$1.62B$1.63B$1.66B$1.69B$1.61B$1.62B$1.58B
Stock-based compensation$121.0M$220.0M$206.0M$274.0M$177.0M$170.0M$203.0M$201.0M$225.0M$272.0M$249.0M$362.0M
Dividends per share$0.83$0.00$0.84$0.00$0.85$0.00$0.86$0.00$0.86$0.00$0.86$0.00

The main figures as JSON and plain text. See data and methodology.

PFE in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.